Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Jun XieXian ZhangSong HuWan-Da PengBin XuYan LiSu-Juan ZhangQing LiChong LiPublished in: Journal of cancer research and clinical oncology (2020)
In our study, stage IB NSCLC did not benefit from adjuvant chemotherapy, even in patients with VPI. However, the significance of adjuvant chemotherapy in patients with VPI is still worth further exploration.